Design and Synthesis of Novel Bis-Imidazolyl Phenyl Butadiyne Derivatives as HCV NS5A Inhibitors
- Supplementary File 1:
ZIP-Document (ZIP, 3103 KiB)
Hamdy, J.; Emadeldin, N.; Hamed, M.M.; Frakolaki, E.; Katsamakas, S.; Vassilaki, N.; Zoidis, G.; Hirsch, A.K.H.; Abdel-Halim, M.; Abadi, A.H. Design and Synthesis of Novel Bis-Imidazolyl Phenyl Butadiyne Derivatives as HCV NS5A Inhibitors. Pharmaceuticals 2022, 15, 632. https://doi.org/10.3390/ph15050632
Hamdy J, Emadeldin N, Hamed MM, Frakolaki E, Katsamakas S, Vassilaki N, Zoidis G, Hirsch AKH, Abdel-Halim M, Abadi AH. Design and Synthesis of Novel Bis-Imidazolyl Phenyl Butadiyne Derivatives as HCV NS5A Inhibitors. Pharmaceuticals. 2022; 15(5):632. https://doi.org/10.3390/ph15050632
Chicago/Turabian StyleHamdy, Jehad, Nouran Emadeldin, Mostafa M. Hamed, Efseveia Frakolaki, Sotirios Katsamakas, Niki Vassilaki, Grigoris Zoidis, Anna K.H. Hirsch, Mohammad Abdel-Halim, and Ashraf H. Abadi. 2022. "Design and Synthesis of Novel Bis-Imidazolyl Phenyl Butadiyne Derivatives as HCV NS5A Inhibitors" Pharmaceuticals 15, no. 5: 632. https://doi.org/10.3390/ph15050632